US 8183009
Assaying cellular markers for the evaluation of tumors
granted A61PA61P17/02A61P31/00
Quick answer
US patent 8183009 (Assaying cellular markers for the evaluation of tumors) held by Precision Therapeutics, Inc. expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Precision Therapeutics, Inc.
- Grant date
- Tue May 22 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P17/02, A61P31/00, A61P35/00, A61P37/02